Document Detail

Intravascular ultrasound findings in ENDEAVOR II and ENDEAVOR III.
MedLine Citation:
PMID:  17950835     Owner:  NLM     Status:  MEDLINE    
The results of 2 randomized controlled trials of the Endeavor zotarolimus-eluting stent (ZES; Medtronic Vascular, Santa Rosa, CA) were recently reported: ENDEAVOR II, in which the Endeavor stent was compared with the Driver bare metal stent (BMS; Medtronic Vascular), and ENDEAVOR III, in which the Endeavor stent was compared with the first-generation Cypher sirolimus-eluting stent (SES; Cordis Corporation, Miami Lakes, FL). To examine in detail the vascular responses to the Endeavor stent, serial intravascular ultrasound (IVUS) analyses were performed in subsets of patients in the 2 trials at baseline and 8-month follow-up. The investigators report results for various IVUS parameters and compare those with published results for the first-generation SES and paclitaxel-eluting stent (PES). The ZES demonstrated significantly improved effectiveness and equivalent safety compared with the BMS in ENDEAVOR II. Although the ZES seems to be slightly less effective at inhibiting intimal hyperplasia than the SES and PES, early results are indicative of an acceptable safety profile. This finding may be due in part to the relatively complete and uniform neointimal coverage associated with the ZES.
Ryota Sakurai; Heidi N Bonneau; Yasuhiro Honda; Peter J Fitzgerald
Related Documents :
15614345 - Very late in-stent restenosis (five years) presenting as an st elevation acute myocardi...
11705825 - Intracoronary beta-radiation exacerbates long-term neointima formation in balloon-injur...
14608145 - Treatment of in-stent restenosis in a gastroepiploic artery coronary bypass graft with ...
21076885 - Evaluation of coronary artery in-stent restenosis with prospectively ecg-triggered axia...
12923025 - Clinical and angiographic outcome of directional atherectomy followed by stent implanta...
1724965 - A comparison of endothelium-derived relaxing factor activity in the coronary and renal ...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  The American journal of cardiology     Volume:  100     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-22     Completed Date:  2007-12-06     Revised Date:  2008-06-05    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  71M-76M     Citation Subset:  AIM; IM    
Center for Cardiovascular Technology, Stanford University Medical Center, Stanford, California 94305-5637, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / administration & dosage,  therapeutic use*
Coronary Disease / drug therapy*
Double-Blind Method
Drug-Eluting Stents*
Follow-Up Studies
Middle Aged
Sirolimus / administration & dosage,  analogs & derivatives*,  therapeutic use
Tunica Intima / drug effects,  pathology*,  ultrasonography
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/zotarolimus; 53123-88-9/Sirolimus

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The relation between clinical features, angiographic findings, and the target lesion revascularizati...
Next Document:  Real-world safety and efficacy of the endeavor zotarolimus-eluting stent: early data from the E-Five...